E
Enveric Biosciences, Inc. ENVB
$1.45 $0.12089.09% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 6.15% 38.27% 44.63% 56.26% 52.26%
Total Depreciation and Amortization -17.75% -12.37% -17.28% -17.98% -20.20%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -9.18% -39.01% -34.73% -58.94% -50.61%
Change in Net Operating Assets 195.49% -280.97% -142.16% -405.90% -441.49%
Cash from Operations 34.66% 34.93% 45.18% 48.34% 43.35%
Capital Expenditure -- -- -- 100.00% 100.00%
Sale of Property, Plant, and Equipment -- -- -- -100.59% -100.59%
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -- -- -- -100.00% 100.00%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 16.84% 10.64% -- -- -35.47%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -106.83% -115.31% 220.83% 225.94% --
Cash from Financing -8.16% 2.81% 671.31% 707.06% -5.47%
Foreign Exchange rate Adjustments -728.57% -137.22% 153.00% -159.73% 98.03%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 81.76% 66.78% 99.70% 93.18% 67.25%